Check Social Media for Details About Our On-Campus Events.
About geminismith
-
Academic Level Medical
-
Age 23 - 27 Years
-
Salary 2387
-
Industry Development
-
Viewed 3
About me
A candidate antibody drug for prevention of malaria​ is showing promise in the battle against this pervasive and deadly disease. By specifically targeting the malaria-causing parasite, this novel antibody drug aims to inhibit its life cycle and prevent it from infecting red blood cells. Unlike traditional antimalarial treatments, which often face challenges like drug resistance, a candidate antibody drug offers a targeted approach with the potential for long-lasting immunity and fewer side effects. As research progresses, such antibody drugs could revolutionize malaria prevention strategies and provide a powerful tool in global efforts to eradicate this life-threatening disease.